These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 4522072

  • 1. Clinical aspects of side effects on intermittent rifampicin regimen.
    Zierski M.
    Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
    [No Abstract] [Full Text] [Related]

  • 2. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ.
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract] [Full Text] [Related]

  • 3. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
    Girling DJ.
    Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
    [No Abstract] [Full Text] [Related]

  • 4. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
    Anastasatu C, Bungeteanu G, Sibila S.
    Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
    [No Abstract] [Full Text] [Related]

  • 5. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V.
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract] [Full Text] [Related]

  • 6. Side effects observed during intermittent rifampicin therapy.
    Stradling P.
    Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
    [No Abstract] [Full Text] [Related]

  • 7. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ.
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Haematological changes during intermittent treatment with rifampicin.
    Wislawska-Orlowska B, Pniewski T.
    Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
    [No Abstract] [Full Text] [Related]

  • 10. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M.
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract] [Full Text] [Related]

  • 11. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
    Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
    Eule H, Kärnbach E, Kaluza P, Herrmann H.
    Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H, Werner E, Winsel K, Iwainsky H.
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract] [Full Text] [Related]

  • 15. Acute renal failure due to rifampicin.
    Agnihotri MS, Bansal S, Kumar A.
    Indian J Chest Dis Allied Sci; 1990 Mar; 32(2):125-8. PubMed ID: 2083961
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J.
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract] [Full Text] [Related]

  • 18. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.